IMpower010: Phase III Study of Atezolizumab vs BSC after Adjuvant Chemotherapy in Patients with Completely Resected NSCLC Wakelee, H., Altorki, N., Vallieres, E., Zhou, C., Zuo, Y., Howland, M., Xia, F., Hoang, T., Sandler, A., Felip, E. ELSEVIER SCIENCE INC. 2017: S1305

View details for Web of Science ID 000413055803094